VOICED : AstraZeneca sufre revés en desarrollo de tratamiento anticovid

VOICED : AstraZeneca sufre revés en desarrollo de tratamiento anticovid

Assessment

Interactive Video

Biology, Science, Health, Medicine

9th - 12th Grade

Hard

Created by

Quizizz Content

FREE Resource

AstraZeneca announced a setback in their COVID-19 treatment development, as their antibody procedure failed to prevent symptomatic cases in a phase 3 trial. The trial involved 1,121 unvaccinated adults exposed to the virus, showing only a 33% reduction in symptomatic risk. Despite this, research continues for pre-exposure and severe cases. Concurrently, AstraZeneca faces challenges with their vaccine, suspended in some European countries due to blood-related issues.

Read more

1 questions

Show all answers

1.

OPEN ENDED QUESTION

3 mins • 1 pt

What new insight or understanding did you gain from this video?

Evaluate responses using AI:

OFF